Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Metformin is less effective in men with early-onset hair loss.

Many women with PCOS have abnormal cholesterol levels, needing careful management.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

Nutraceutical insulin-sensitizing agents may help treat skin conditions like psoriasis and acne.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

People with acne tend to have lower iron levels.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

New drug uses show promise but need more research.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.